Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences. (2019)

Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Modeling and simulation of the modified Rankin Scale and National Institutes of Health Stroke Scale neurological endpoints in intracerebral hemorrhage. (2019)

Effect of plasma exchange on the pharmacokinetics and pharmacodynamics of Caplacizumab, PS1487.

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Effect of plasma exchange on the pharmacokinetics and pharmacodynamics of Caplacizumab, PS1487.

Caplacizumab model-based dosing recommendations in pediatric patients with acquired thrombotic thrombocytopenic purpura, PB2249.

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Caplacizumab model-based dosing recommendations in pediatric patients with acquired thrombotic thrombocytopenic purpura, PB2249.

Sensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity Studies. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Sensitivity of Pegfilgrastim Pharmacokinetic and Pharmacodynamic Parameters to Product Differences in Similarity Studies. (2019)

Caplacizumab Dosing Rational in aTTP Patients Supported by Mechanism Based PKPD Modelling. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Caplacizumab Dosing Rational in aTTP Patients Supported by Mechanism Based PKPD Modelling. (2019)

Assessment of expected drug exposure relative maximum safety limits in early phase studies. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Assessment of expected drug exposure relative maximum safety limits in early phase studies. (2019)

Model based support to biosimilarity assessment planning – A case study of pegfilgrastim. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Model based support to biosimilarity assessment planning – A case study of pegfilgrastim. (2019)

Implicit and efficient handling of missing covariate information using full random effects modelling. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading Implicit and efficient handling of missing covariate information using full random effects modelling. (2019)

A PBPK Framework to Predict Drug Exposure in Malnourished Children. (2019)

• Post author:Stefan Silver
• Post published:July 8, 2019
• Post category:

Continue Reading A PBPK Framework to Predict Drug Exposure in Malnourished Children. (2019)